The first Phase 3 clinical trial of a coronavirus vaccine in development by biotech company Moderna together with the National Institute of Allergy and Infectious Diseases (part of the National Institutes of Health), began Monday.
Moderna is among a handful of companies that are funded by the US government under its Operation Warp Speed COVID-19 vaccine program. Three other vaccine trials will be launching Phase 3 trials soon as well – each with 30,000 volunteers as part of Operation Warp Speed.
